Skip to content
Home/Companies/Biotech/Concert Bio
CB

Concert Bio

Biotech·United Kingdom·Active·4yr hold

Concert Bio is a biotech company, headquartered in United Kingdom.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Concert Bio?

Concert Bio is currently owned by Nucleus Capital through Nucleus Capital I (2021 vintage), since 2022.

Hand-verified · updated 2026-07-03

Nucleus Capital
Investor
Nucleus Capital
Nucleus Capital I · 2021 · VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

More from Nucleus Capital I

Other portfolio companies in the same fund.

atmio
Active
SoftwareGermany· 2023
Biographica
Active
BiotechUnited Kingdom· 2023
Biomia
Active
BiotechDenmark· 2023
Brineworks
Active
EnergyNetherlands· 2023
Endolith
Active
IndustrialsUnited States· 2023
Farmless
Active
BiotechNetherlands· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings